Copyright
©2012 Baishideng.
World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 7-20
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Children (because they are exposed to the long-term physical presence of stones[58]) |
Morbid obese patients undergoing bariatric surgery (high risk to become symptomatic during rapid weight loss[62]) |
Increased risk for gallbladder cancer[63] |
Patients with large gallstones (greater than 3 cm)[64,65] |
A “porcelain” gallbladder[66] or gallbladder polyps rapidly growing or larger than 1 cm |
Native Americans with gallstones (risk of gallbladder cancer 3 to 5 percent)[67] |
Gallstone patients with sickle cell anemia (formation of calcium bilirubinate gallstones due to chronic hemolysis. Patients may become symptomatic with recurrent episodes of abdominal pain[68]) |
Coexistence of small gallstones and gallbladder dysmotility (increased risk of pancreatitis[47]) |
- Citation: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20
- URL: https://www.wjgnet.com/2150-5349/full/v3/i2/7.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.7